“The East/West CEO meeting has provided a unique opportunity for senior life sciences executives to network with business colleagues and thought leaders, reflect on the past year’s events and key drivers for strategy in the year ahead."- Arthur Hiller, Chief Corporate Development Officer, Nuritas.
SAN FRANCISCO (PRWEB) November 06, 2019
LeadingBiotech, an exclusive event series bringing together senior-level biopharma leaders through off-the-record collaboration and dialogue, today announces its East/West CEO conference to be held January 11-12, 2020 at the Four Seasons Hotel in San Francisco.
Kicking off the week of the J.P. Morgan Healthcare Conference and other biotech industry conferences, collectively referred to as JPM week, East/West CEO offers executives the opportunity to leverage insight from global leaders in the biopharma community. C-level executives, VPs, directors and partners will examine the industry outlook for 2020 and beyond, network and discuss pressing industry topics with peers.
“The East/West CEO meeting has for nearly a decade provided a unique opportunity for senior life sciences executives to network with business colleagues and thought leaders, reflect on the past year’s events and the key drivers for strategy and decision making in the year ahead, in advance of the JP Morgan conference marathon,” said Arthur Hiller, Chief Corporate Development Officer at Nuritas.
Register before November 15 to save $400 with the early bird rate. To secure a spot at the conference, register here.
Several of the key topics to be discussed include the status of diversity in leadership, Asian markets, ecosystem building in Europe, the impact of machine learning, and the evolving US biotech landscape.
Key session speakers at the conference include:
- Andrew Allen, CEO, Gritstone Oncology
- Hubert Birner, Managing Partner, TVM Capital Life Sciences
- Sangeeta Bhatia, John J. and Dorothy Wilson Professor of Health Sciences and Technology and of Electrical Engineering and Computer Science, MIT
- Jens Eckstein, Managing Partner, Apollo Ventures
- Brian Wallach, Co-Founder, I AM ALS
- Brandon Allgood, Ph.D., VP, Head of Technology and Innovation, Integral Health
- Onno van de Stolpe, CEO, Galapagos
- Marianne De Backer, EVP Global Head of BD & Licensing, Bayer Pharmaceuticals
See full agenda here.
Formerly known as Boston Biotech Conferences, LeadingBiotech is an event series that brings biopharma CEOs and leaders together through intimate, off-the-record collaboration. We are working hard to create more valuable experiences to re-energize collaboration and infuse fresh ideas to better shape the future of biotech. For more information, please visit: https://leadingbiotech.com/.